Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 36865

Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol)


Dumontet, C.; Duran, G.E.; Steger, K.A.; Beketić-Orešković, Lidija; Šikić, B.I.
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol) // Cancer research, 56 (1996), 5; 1091-1097 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 36865 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol)

Autori
Dumontet, C. ; Duran, G.E. ; Steger, K.A. ; Beketić-Orešković, Lidija ; Šikić, B.I.

Izvornik
Cancer research (0008-5472) 56 (1996), 5; 1091-1097

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
resistance mechanisms ; paclitaxel (taxol)

Sažetak
A fluctuation analysis experiment was performed by exposing 15 expanded populations of MES-SA sarcoma cells to paclitaxel (Taxol) at a concentration of 10 nM for 7 days, The mutation rate was approximately 8 x 10(-7)/cell generation. ANOVA supports a stochastic cell survival mechanism of spontaneous mutation rather than induction of an adaptive response under these selection conditions, Surviving colonies were found in 12 populations, 9 of which had clones that remained resistant to paclitaxel after a 2-month period of propagation, Analysis of mdr1 gene expression by reverse transcription PCR demonstrated positive clones in 4 of the 9 populations with stable resistance, Accumulation of [H-3]paclitaxel was decreased in these clones but not in the mdr1-negative clones compared with parental cells. A high degree of resistance to paclitaxel (36- to 93-fold) was selected by this single drug exposure in all 9 stably resistant mutants, Those with mdr1 activation demonstrated a broad cross-resistance to vinblastine, doxorubicin, and etoposide, whereas the other 6 mutants were cross-resistant only to the Vinca alkaloids, Because tubulins are the target molecules for paclitaxel cytotoxicity, we evaluated total tubulin content by immunoblotting and performed semiquantitative reverse transcription PCR analysis for expression of the alpha-tubulin isotypes B alpha 1, K alpha 1 and H alpha 44, the beta-tubulin isotypes M40, beta 9, 5 beta, beta 2 and beta 4, and gamma-tubulin. Total tubulin content was decreased significantly in one of the single-step mutants, All surviving clones, both resistant and sensitive to paclitaxel, displayed reduced expression of the 5 beta and the beta 4 beta-tubulin isotype transcripts in comparison with the parental cell line, These data suggest that stringent exposure to paclitaxel selected clones with reduced transcript levels of 5 beta and beta 4 beta-tubulin isotypes, but that these reduced levels were not directly involved in the resistance of the clones to paclitaxel, The results suggest an important role for non-multidrug-resistant mechanisms of resistance to paclitaxel. These mechanisms do not involve reduced drug accumulation and provide cross-resistance among both paclitaxel and tubulin depolymerizing agents.

Izvorni jezik
Engleski

Znanstvena područja
Biologija



POVEZANOST RADA


Projekti:
00981008

Ustanove:
Institut "Ruđer Bošković", Zagreb

Poveznice na cjeloviti tekst rada:

cancerres.aacrjournals.org cancerres.aacrjournals.org

Citiraj ovu publikaciju:

Dumontet, C.; Duran, G.E.; Steger, K.A.; Beketić-Orešković, Lidija; Šikić, B.I.
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol) // Cancer research, 56 (1996), 5; 1091-1097 (međunarodna recenzija, članak, znanstveni)
Dumontet, C., Duran, G., Steger, K., Beketić-Orešković, L. & Šikić, B. (1996) Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol). Cancer research, 56 (5), 1091-1097.
@article{article, author = {Dumontet, C. and Duran, G.E. and Steger, K.A. and Beketi\'{c}-Ore\v{s}kovi\'{c}, Lidija and \v{S}iki\'{c}, B.I.}, year = {1996}, pages = {1091-1097}, keywords = {resistance mechanisms, paclitaxel (taxol)}, journal = {Cancer research}, volume = {56}, number = {5}, issn = {0008-5472}, title = {Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol)}, keyword = {resistance mechanisms, paclitaxel (taxol)} }
@article{article, author = {Dumontet, C. and Duran, G.E. and Steger, K.A. and Beketi\'{c}-Ore\v{s}kovi\'{c}, Lidija and \v{S}iki\'{c}, B.I.}, year = {1996}, pages = {1091-1097}, keywords = {resistance mechanisms, paclitaxel (taxol)}, journal = {Cancer research}, volume = {56}, number = {5}, issn = {0008-5472}, title = {Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol)}, keyword = {resistance mechanisms, paclitaxel (taxol)} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font